Marc Goemans, DSM Biologics. DSM's blueprint for its 'biologics plant of the future'




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Marc Goemans, DSM Biologics. DSM's blueprint for its 'biologics plant of the future'
Released on: March 27, 2014. © PTV
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    This interview was filmed prior to the formation of DPx.
  • Summary
  • Transcript
  • Participants
  • Company
This interview was filmed prior to the formation of DPx. In this interview filmed during the AusBiotec Convention 2013, Fintan Walton catches up with Marc Goemans of DSM Biologics. They talk about the opening of new cGMP facility for biopharmaceutical manufacturing in Brisbane, Australia. The facility was built in partnership with Biopharmaceuticals Australia with cooperation from the government of Queensland and the Commonwealth of Australia. This world-class operation in the Asia-Pacific region is an important growth area in DSM’s strategic development in the biopharmaceutical field. The facility was designed by an expert international team of biological scientists and bioengineers, utilizing DSM's twenty seven years of experience in mammalian cell culture processing to construct a purpose-built, state-of-the-art biomanufacturing facility. The Brisbane facility offers cGMP mammalian cell culture contract manufacturing services from process development through to commercial manufacturing.
This interview was filmed prior to the formation of DPx. In this interview filmed during the AusBiotec Convention 2013, Fintan Walton catches up with Marc Goemans of DSM Biologics. They talk about the opening of new cGMP facility for biopharmaceutical manufacturing in Brisbane, Australia. The facility was built in partnership with Biopharmaceuticals Australia with cooperation from the government of Queensland and the Commonwealth of Australia. This world-class operation in the Asia-Pacific region is an important growth area in DSM’s strategic development in the biopharmaceutical field. The facility was designed by an expert international team of biological scientists and bioengineers, utilizing DSM's twenty seven years of experience in mammalian cell culture processing to construct a purpose-built, state-of-the-art biomanufacturing facility. The Brisbane facility offers cGMP mammalian cell culture contract manufacturing services from process development through to commercial manufacturing.
Marc Goemans
DSM Biologics
DSM Biologics
DSM has established its position over 20 years to become one of the leading providers of custom manufacturing in the global pharmaceutical and biopharmaceutical markets.